Oklo Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
OKLO$25.09-6.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(9,810) | $(24,022) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 124 | 49 |
| Change in fair value of simple agreements for future equity | — | 16,793 |
| Accretion of discount on marketable debt securities | (312) | — |
| Stock-based compensation | 2,311 | 667 |
| Deferred income taxes | (4,734) | — |
| Change in operating assets and liabilities, net of effect of acquisition: | ||
| Prepaid and other current assets | 336 | (291) |
| Other assets | (17) | 25 |
| Accounts payable | (1,755) | (574) |
| Accrued expenses and other | 1,606 | 73 |
| Operating lease right-of-use assets and liabilities | 8 | (7) |
| Net cash used in operating activities | (12,243) | (7,287) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (332) | (97) |
| Purchases of marketable debt securities | (29,887) | — |
| Proceeds from redemptions of marketable debt securities | 37,183 | — |
| Payment for acquisition of business, net of cash acquired | (900) | — |
| Net cash provided by (used in) investing activities: | 6,064 | (97) |
| Cash flows from financing activities: | ||
| Payment of taxes from common stock withheld | (1,595) | — |
| Proceeds from exercise of stock options | 720 | 440 |
| Proceeds from right of first refusal liability | — | 25,000 |
| Proceeds from simple agreements for future equity | — | 10,232 |
| Payment of deferred issuance costs | — | (137) |
| Net cash (used in) provided by financing activities | (875) | 35,535 |
| Net (decrease) increase in cash and cash equivalents | (7,054) | 28,151 |
| Cash and cash equivalents - beginning of period | 97,132 | 9,868 |
| Cash and cash equivalents - end of period | $90,078 | $38,019 |
| Supplemental noncash investing and financing activities: | ||
| Issuance of common stock in connection with acquisition of business | $27,408 | $— |
| Assumed liabilities in connection with acquisition of business | 287 | — |
| Deferred issuance costs included in accounts payable | — | 800 |
| Deferred issuance costs included in accrued expense and other | — | 204 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.